Atlas Trials

Sacituzumab Tirumotecan in Previously Treated TROP2-Positive Advanced Biliary Tract Cancer

Clinical trial NCT07701122 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07701122
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Biliary Tract Cancer(BTC)
Start date
2026-07-01
Primary completion
2027-07-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.